|
Market Closed -
NYSE
16:10:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 40.82 USD | +4.35% |
|
-5.20% | +5.86% |
Main features
| US26923G3011 | Fees | 0.65% | Dividend Policy | Distribution | |
|---|---|---|---|---|---|
| Currency | USD | AuM (CAD) | 79.36M | Replication Method | Direct (Physical) |
| Number of securities | 110 | AuM evolution | - | Date of creation | 2014-12-15 |
NYSEUSD
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BBC | Delayed | |
CBOE
| BBC | Real-time |
| Name |
Off-Hours Price |
Change |
Weight | |
|---|---|---|---|---|
 | 6.340USD | +3.59% | 1.87% | |
| 9.650USD | +1.37% | 1.6% | |
| 3.700USD | +3.35% | 1.38% | |
| 14.00USD | +0.14% | 1.32% | |
| 115.07USD | +0.03% | 1.23% | |
| 58.02USD | +0.07% | 1.22% | |
| 19.34USD | +4.43% | 1.14% | |
| 11.58USD | +1.40% | 1.13% | |
| 1.300USD | -0.76% | 1.07% | |
| 23.53USD | +6.76% | 1.06% | |
Easily sort and filter through all available ETFs
Access the ETF ScreenerEconomic news
In partnership with
Investment objective
| Asset Classes | Stocks |
|---|---|
| Geographical Focus | United States |
| Theme and Sector | Tomorrow's Treatments |
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | US$40.82 | +4.35% | 85,965 |
| 26-10-16 | US$39.12 | -4.96% | 85,449 |
| 26-10-15 | US$41.16 | +2.51% | 44,962 |
| 26-10-14 | US$40.15 | -1.20% | 86,465 |
| 26-10-13 | US$40.64 | -5.61% | 52,877 |
- Stock Market
- ETF
- BBC ETF
Select your edition
All financial news and data tailored to specific country editions
